ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling performance using the ICR142 NGS validation series
Evaluating, optimising and benchmarking of next generation sequencing (NGS) variant calling performance are essential requirements for clinical, commercial and academic NGS pipelines. Such assessments should be performed in a consistent, transparent and reproducible fashion, using independently, ort...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234721/ https://www.ncbi.nlm.nih.gov/pubmed/30483600 http://dx.doi.org/10.12688/wellcomeopenres.14754.2 |
_version_ | 1783370761687269376 |
---|---|
author | Ruark, Elise Holt, Esty Renwick, Anthony Münz, Márton Wakeling, Matthew Ellard, Sian Mahamdallie, Shazia Yost, Shawn Rahman, Nazneen |
author_facet | Ruark, Elise Holt, Esty Renwick, Anthony Münz, Márton Wakeling, Matthew Ellard, Sian Mahamdallie, Shazia Yost, Shawn Rahman, Nazneen |
author_sort | Ruark, Elise |
collection | PubMed |
description | Evaluating, optimising and benchmarking of next generation sequencing (NGS) variant calling performance are essential requirements for clinical, commercial and academic NGS pipelines. Such assessments should be performed in a consistent, transparent and reproducible fashion, using independently, orthogonally generated data. Here we present ICR142 Benchmarker, a tool to generate outputs for assessing germline base substitution and indel calling performance using the ICR142 NGS validation series, a dataset of Illumina platform-based exome sequence data from 142 samples together with Sanger sequence data at 704 sites. ICR142 Benchmarker provides summary and detailed information on the sensitivity, specificity and false detection rates of variant callers. ICR142 Benchmarker also automatically generates a single page report highlighting key performance metrics and how performance compares to widely-used open-source tools. We used ICR142 Benchmarker with VCF files outputted by GATK, OpEx and DeepVariant to create a benchmark for variant calling performance. This evaluation revealed pipeline-specific differences and shared challenges in variant calling, for example in detecting indels in short repeating sequence motifs. We next used ICR142 Benchmarker to perform regression testing with DeepVariant versions 0.5.2 and 0.6.1. This showed that v0.6.1 improves variant calling performance, but there was evidence of minor changes in indel calling behaviour that may benefit from attention. The data also allowed us to evaluate filters to optimise DeepVariant calling, and we recommend using 30 as the QUAL threshold for base substitution calls when using DeepVariant v0.6.1. Finally, we used ICR142 Benchmarker with VCF files from two commercial variant calling providers to facilitate optimisation of their in-house pipelines and to provide transparent benchmarking of their performance. ICR142 Benchmarker consistently and transparently analyses variant calling performance based on the ICR142 NGS validation series, using the standard VCF input and outputting informative metrics to enable user understanding of pipeline performance. ICR142 Benchmarker is freely available at https://github.com/RahmanTeamDevelopment/ICR142_Benchmarker/releases. |
format | Online Article Text |
id | pubmed-6234721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-62347212018-11-26 ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling performance using the ICR142 NGS validation series Ruark, Elise Holt, Esty Renwick, Anthony Münz, Márton Wakeling, Matthew Ellard, Sian Mahamdallie, Shazia Yost, Shawn Rahman, Nazneen Wellcome Open Res Software Tool Article Evaluating, optimising and benchmarking of next generation sequencing (NGS) variant calling performance are essential requirements for clinical, commercial and academic NGS pipelines. Such assessments should be performed in a consistent, transparent and reproducible fashion, using independently, orthogonally generated data. Here we present ICR142 Benchmarker, a tool to generate outputs for assessing germline base substitution and indel calling performance using the ICR142 NGS validation series, a dataset of Illumina platform-based exome sequence data from 142 samples together with Sanger sequence data at 704 sites. ICR142 Benchmarker provides summary and detailed information on the sensitivity, specificity and false detection rates of variant callers. ICR142 Benchmarker also automatically generates a single page report highlighting key performance metrics and how performance compares to widely-used open-source tools. We used ICR142 Benchmarker with VCF files outputted by GATK, OpEx and DeepVariant to create a benchmark for variant calling performance. This evaluation revealed pipeline-specific differences and shared challenges in variant calling, for example in detecting indels in short repeating sequence motifs. We next used ICR142 Benchmarker to perform regression testing with DeepVariant versions 0.5.2 and 0.6.1. This showed that v0.6.1 improves variant calling performance, but there was evidence of minor changes in indel calling behaviour that may benefit from attention. The data also allowed us to evaluate filters to optimise DeepVariant calling, and we recommend using 30 as the QUAL threshold for base substitution calls when using DeepVariant v0.6.1. Finally, we used ICR142 Benchmarker with VCF files from two commercial variant calling providers to facilitate optimisation of their in-house pipelines and to provide transparent benchmarking of their performance. ICR142 Benchmarker consistently and transparently analyses variant calling performance based on the ICR142 NGS validation series, using the standard VCF input and outputting informative metrics to enable user understanding of pipeline performance. ICR142 Benchmarker is freely available at https://github.com/RahmanTeamDevelopment/ICR142_Benchmarker/releases. F1000 Research Limited 2018-10-31 /pmc/articles/PMC6234721/ /pubmed/30483600 http://dx.doi.org/10.12688/wellcomeopenres.14754.2 Text en Copyright: © 2018 Ruark E et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Software Tool Article Ruark, Elise Holt, Esty Renwick, Anthony Münz, Márton Wakeling, Matthew Ellard, Sian Mahamdallie, Shazia Yost, Shawn Rahman, Nazneen ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling performance using the ICR142 NGS validation series |
title | ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling performance using the ICR142 NGS validation series |
title_full | ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling performance using the ICR142 NGS validation series |
title_fullStr | ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling performance using the ICR142 NGS validation series |
title_full_unstemmed | ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling performance using the ICR142 NGS validation series |
title_short | ICR142 Benchmarker: evaluating, optimising and benchmarking variant calling performance using the ICR142 NGS validation series |
title_sort | icr142 benchmarker: evaluating, optimising and benchmarking variant calling performance using the icr142 ngs validation series |
topic | Software Tool Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234721/ https://www.ncbi.nlm.nih.gov/pubmed/30483600 http://dx.doi.org/10.12688/wellcomeopenres.14754.2 |
work_keys_str_mv | AT ruarkelise icr142benchmarkerevaluatingoptimisingandbenchmarkingvariantcallingperformanceusingtheicr142ngsvalidationseries AT holtesty icr142benchmarkerevaluatingoptimisingandbenchmarkingvariantcallingperformanceusingtheicr142ngsvalidationseries AT renwickanthony icr142benchmarkerevaluatingoptimisingandbenchmarkingvariantcallingperformanceusingtheicr142ngsvalidationseries AT munzmarton icr142benchmarkerevaluatingoptimisingandbenchmarkingvariantcallingperformanceusingtheicr142ngsvalidationseries AT wakelingmatthew icr142benchmarkerevaluatingoptimisingandbenchmarkingvariantcallingperformanceusingtheicr142ngsvalidationseries AT ellardsian icr142benchmarkerevaluatingoptimisingandbenchmarkingvariantcallingperformanceusingtheicr142ngsvalidationseries AT mahamdallieshazia icr142benchmarkerevaluatingoptimisingandbenchmarkingvariantcallingperformanceusingtheicr142ngsvalidationseries AT yostshawn icr142benchmarkerevaluatingoptimisingandbenchmarkingvariantcallingperformanceusingtheicr142ngsvalidationseries AT rahmannazneen icr142benchmarkerevaluatingoptimisingandbenchmarkingvariantcallingperformanceusingtheicr142ngsvalidationseries |